Application of genetic features and serial ctDNA in estimating response and prognosis of immunotherapy-based total neoadjuvant therapy (iTNT) for microsatellite stable locally advanced rectal cancer: data from TORCH trial

Genome Medicine · Published 2026-09-02 · Journal article · DOI 10.1186/s13073-026-01755-2

Free full text

Authors (23)

Yaqi Wang, Yang Xu, Yingxuan Lin, Yujun Liu, Qifan Jing, Lijun Shen, Juefeng Wan, Yan Wang, Hui Zhang, Ruiyan Wu, Shujuan Zhou, Yajie Chen, Zhiyuan Zhang, Jingwen Wang, Yiqun Sun, Hairong Bao, Qiuxiang Ou, Hua Bao, Yang Shao, Sanjun Cai, Ye Xu, Zhen Zhang, Fan Xia

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Wang, Y., Xu, Y., Lin, Y., et al. (2026). Application of genetic features and serial ctDNA in estimating response and prognosis of immunotherapy-based total neoadjuvant therapy (iTNT) for microsatellite stable locally advanced rectal cancer: data from TORCH trial. Genome Medicine. https://doi.org/10.1186/s13073-026-01755-2

Related articles